Edner, Natalie M. http://orcid.org/0000-0003-2799-2890
Heuts, Frank
Thomas, Niclas
Wang, Chun Jing
Petersone, Lina http://orcid.org/0000-0001-8571-9185
Kenefeck, Rupert
Kogimtzis, Alexandros
Ovcinnikovs, Vitalijs
Ross, Ellen M.
Ntavli, Elisavet
Elfaki, Yassin http://orcid.org/0000-0001-6628-3080
Eichmann, Martin http://orcid.org/0000-0002-8675-2822
Baptista, Roman
Ambery, Philip
Jermutus, Lutz
Peakman, Mark
Rosenthal, Miranda
Walker, Lucy S. K. http://orcid.org/0000-0001-5986-5015
Funding for this research was provided by:
British Dietetic Association (15/0005253)
RCUK | MRC | Medical Research Foundation (MR/N001435/1)
Rosetrees Trust (M514)
AstraZeneca
EC | Horizon 2020 Framework Programme (675395)
Article History
Received: 12 September 2019
Accepted: 23 June 2020
First Online: 3 August 2020
Competing interests
: AstraZeneca contributed to the funding of the study. P.A. and L.J. declare an interest in developing costimulation blockade reagents at AstraZeneca. L.S.K.W. and N.T. are inventors on a patent application related to these findings.